Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives.

[1]  C. Pepine,et al.  Does Patient-Physician Gender Concordance Influence Patient Perceptions or Outcomes? , 2021, Journal of the American College of Cardiology.

[2]  Deepak L. Bhatt,et al.  Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials , 2021, Circulation.

[3]  K. Freund,et al.  Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations , 2021, JCO oncology practice.

[4]  P. Greenland,et al.  Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States. , 2020, Journal of the American College of Cardiology.

[5]  C. Vidaillac,et al.  Towards a fair and transparent research participant compensation and reimbursement framework in Vietnam , 2020, International health.

[6]  J. Shults,et al.  Association of Racial/Ethnic and Gender Concordance Between Patients and Physicians With Patient Experience Ratings , 2020, JAMA network open.

[7]  S. Solomon,et al.  Conduct of Clinical Trials in the Era of COVID-19 , 2020, Journal of the American College of Cardiology.

[8]  P. Douglas,et al.  Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors. , 2020, Journal of the American College of Cardiology.

[9]  K. Rexrode,et al.  Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association. , 2020, Circulation.

[10]  E. Peterson,et al.  Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy. , 2020, JAMA internal medicine.

[11]  Tracy Y. Wang,et al.  Time to End "Manels" in Clinical Trial Leadership. , 2020, JAMA internal medicine.

[12]  M. Walsh,et al.  Representation of Women in Cardiovascular Clinical Trial Leadership. , 2020, JAMA internal medicine.

[13]  G. Breithardt,et al.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[14]  I. Piña,et al.  Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials , 2020, Circulation. Heart failure.

[15]  R. Farrell,et al.  Pregnant Women in Trials of Covid‐19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials , 2020, Ethics & human research.

[16]  C. Blyler,et al.  Barbershop Management of Hypertension in the African American Population: Pitfalls and Opportunities for Extension to Other Underserved Communities , 2020, Current Cardiology Reports.

[17]  M. Link,et al.  Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure , 2020, Circulation.

[18]  J. Wyatt,et al.  Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map , 2020, Trials.

[19]  Kirk A Easley,et al.  Overcoming barriers to recruitment and retention of African–American women with SLE in behavioural interventions: lessons learnt from the WELL study , 2020, Lupus science & medicine.

[20]  M. Khan,et al.  Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs , 2020, Journal of the American Heart Association.

[21]  M. Landon,et al.  Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries , 2020, American Journal of Perinatology.

[22]  A. Perotte,et al.  Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations. , 2020, npj Digital Medicine.

[23]  F. Rutten,et al.  Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta‐analysis , 2020, Journal of the American Heart Association.

[24]  T. Revenson,et al.  Racial/ethnic concordance between patients and researchers as a predictor of study attrition. , 2020, Social science & medicine.

[25]  Deepak L. Bhatt,et al.  Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. , 2020, JAMA cardiology.

[26]  Lijing L. Yan,et al.  Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017 , 2020, Circulation.

[27]  M. Abrahamowicz,et al.  Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure , 2020, CJC open.

[28]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[29]  E. Antman,et al.  Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes. , 2019, Journal of the American College of Cardiology.

[30]  C. Yancy,et al.  Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success. , 2019, Circulation.

[31]  Marco V Perez,et al.  Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. , 2019, The New England journal of medicine.

[32]  Deepak L. Bhatt,et al.  Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry. , 2019, The American journal of medicine.

[33]  N. Samani,et al.  Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study , 2019, The Lancet.

[34]  Akshay S. Desai,et al.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. , 2019, The New England journal of medicine.

[35]  M. S. Halbreiner,et al.  Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016. , 2019, Circulation. Heart failure.

[36]  T. Simard,et al.  Female Authorship in Preclinical Cardiovascular Research , 2019, JACC. Basic to translational science.

[37]  P. Jhund,et al.  Healthcare disparities for women hospitalised with myocardial infarction and angina. , 2019, European heart journal. Quality of care & clinical outcomes.

[38]  Christine Pierre,et al.  Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. , 2019, Current problems in cardiology.

[39]  Amy E. Judy,et al.  ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease. , 2019, Obstetrics and gynecology.

[40]  G. Hindricks,et al.  Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[41]  M. Walsh,et al.  A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report , 2019, The New England journal of medicine.

[42]  K. Kupzyk,et al.  Contemporary Approaches to Recruitment of Postmenopausal Women for a Community-Based Study. , 2019, Nursing research.

[43]  Rachel Willard-Grace,et al.  Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial , 2019, BMC Medical Research Methodology.

[44]  Deepak L. Bhatt,et al.  Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study , 2019, Circulation.

[45]  E. Hsich.  Sex Differences in Advanced Heart Failure Therapies , 2019, Circulation.

[46]  Letian Zhang,et al.  When Gender Diversity Makes Firms More Productive , 2019 .

[47]  R. Harrington,et al.  Sex Disparities in Authorship Order of Cardiology Scientific Publications: Trends Over 40 Years , 2018, Circulation. Cardiovascular quality and outcomes.

[48]  W. Chaplin,et al.  Cluster Randomized Clinical Trial of FAITH (Faith-Based Approaches in the Treatment of Hypertension) in Blacks: Main Trial Results , 2018, Circulation. Cardiovascular quality and outcomes.

[49]  A. Quyyumi,et al.  Estimated Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on Reproductive-Aged Women. , 2018, Hypertension.

[50]  C. O'connor,et al.  Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review , 2018, JAMA cardiology.

[51]  T. Marwick,et al.  Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction , 2018, Circulation.

[52]  Deepak L. Bhatt,et al.  Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). , 2018, European heart journal.

[53]  R. Dreyer,et al.  Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study , 2018, Journal of the American Heart Association.

[54]  E. Unger,et al.  Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs. , 2018, Journal of the American College of Cardiology.

[55]  R. Elashoff,et al.  A Cluster‐Randomized Trial of Blood‐Pressure Reduction in Black Barbershops , 2018, The New England journal of medicine.

[56]  M. Arnegard,et al.  Taking cardiology clinical trials to the next level: A call to action , 2018, Clinical cardiology.

[57]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[58]  C. Patten,et al.  mHealth Intervention Promoting Cardiovascular Health Among African-Americans: Recruitment and Baseline Characteristics of a Pilot Study , 2018, JMIR research protocols.

[59]  M. Turakhia,et al.  Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation. , 2016, JACC. Clinical electrophysiology.

[60]  Deepak L. Bhatt,et al.  Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program , 2016, Circulation.

[61]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[62]  Buring,et al.  Cardiovascular Disease in Women: Clinical Perspectives. , 2016, Circulation research.

[63]  Katherine Liu,et al.  Women’s involvement in clinical trials: historical perspective and future implications , 2016, Pharmacy practice.

[64]  Gabriel A. Koepp,et al.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. , 2015, The New England journal of medicine.

[65]  Harald H H W Schmidt,et al.  Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. , 2015, European heart journal.

[66]  J. Kwagyan,et al.  Culturally Competent Strategies for Recruitment and Retention of African American Populations into Clinical Trials , 2015, Clinical and translational science.

[67]  Ruoxiang Jiang,et al.  A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. , 2015, JAMA internal medicine.

[68]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[69]  Amanda J. Patterson,et al.  Recruitment and retention of young women into nutrition research studies: practical considerations , 2014, Trials.

[70]  Lesley G. Campbell,et al.  Gender-Heterogeneous Working Groups Produce Higher Quality Science , 2013, PloS one.

[71]  C. Carter,et al.  Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. , 2012, Journal of women's health.

[72]  D. Meyer,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 References Evidence for a Collective Intelligence Factor in the Performance of Human Groups , 2022 .

[73]  R. Macklin.  Enrolling pregnant women in biomedical research , 2010, The Lancet.

[74]  M. Abrahamowicz,et al.  Consultation with cardiologists for persons with new-onset chronic heart failure: a population-based study. , 2009, The Canadian journal of cardiology.

[75]  G. Fonarow,et al.  Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). , 2009, The American journal of cardiology.

[76]  M. Cupples,et al.  Bmc Medical Research Methodology Open Access Identifying Strategies to Maximise Recruitment and Retention of Practices and Patients in a Multicentre Randomised Controlled Trial of an Intervention to Optimise Secondary Prevention for Coronary Heart Disease in Primary Care , 2022 .

[77]  E. Orav,et al.  Differences in Specialist Consultations for Cardiovascular Disease by Race, Ethnicity, Gender, Insurance Status, and Site of Primary Care , 2009, Circulation.

[78]  Molly Carnes,et al.  Women's health and women's leadership in academic medicine: hitting the same glass ceiling? , 2008, Journal of women's health.

[79]  JoAnn E Manson,et al.  Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. , 2007, Archives of internal medicine.

[80]  Anne L. Taylor,et al.  utcomes by Gender in the frican-American Heart Failure Trial , 2006 .

[81]  S. Cotton,et al.  Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) , 2006, Clinical trials.

[82]  Reshma Jagsi,et al.  The "gender gap" in authorship of academic medical literature--a 35-year perspective. , 2006, The New England journal of medicine.

[83]  Vera Regitz-Zagrosek,et al.  Therapeutic implications of the gender-specific aspects of cardiovascular disease , 2006, Nature Reviews Drug Discovery.

[84]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[85]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[86]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[87]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[88]  A. Hoes,et al.  Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. , 2019, JACC. Heart failure.

[89]  ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants. , 2015, Obstetrics and gynecology.

[90]  E. Peterson,et al.  Willingness to participate in cardiac trials. , 2004, The American journal of geriatric cardiology.